Evidence map›Paper›PMID 40748406›Full record

ArticleExtremophiles : life under extreme conditions2025

Actinomycetes from high altitude salt lake Tso-Kar of Ladakh offers bright prospects for antimycobacterial drug discovery especially for drug resistant mycobacteria.

Ishfaq Ahmad Baba, Zubair Ahmad Wani, Mohamad Mosa Mubarak, Zahoor Ahmad

Abstract read
PubMed Publisher
In one paragraph

Article in Extremophiles : life under extreme conditions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ishfaq Ahmad Baba *Clinical Microbiology and PK-PD Division, CSIR-Indian Institute of Integrative Medicine, Sanatnagar, Srinagar, J&K, 190005, India.
Zubair Ahmad Wani *Clinical Microbiology and PK-PD Division, CSIR-Indian Institute of Integrative Medicine, Sanatnagar, Srinagar, J&K, 190005, India.
Mohamad Mosa MubarakClinical Microbiology and PK-PD Division, CSIR-Indian Institute of Integrative Medicine, Sanatnagar, Srinagar, J&K, 190005, India.
Zahoor AhmadClinical Microbiology and PK-PD Division, CSIR-Indian Institute of Integrative Medicine, Sanatnagar, Srinagar, J&K, 190005, India. zahoorap@iiim.res.in.

Funding

Council of Scientific and Industrial Research, India MLP-110011Department of Biotechnology, Ministry of Science and Technology, India GAP-2176Department of Biotechnology, Ministry of Science and Technology, India GAP-2191Department of Biotechnology, Ministry of Science and Technology, India GAP-3103Indian Council of Medical Research GAP-2192Indian Council of Medical Research ICMR-JRF
6 · The paper itself

Abstract

The rise of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (M. tb) has driven the search for new antimycobacterial agents. Our study focused on isolation and characterization of actinomycetes from the hypersaline Tso-Kar Salt lake in Ladakh, India, to explore their antibacterial potential. We isolated 145 bacterial isolates from various soil, salt and water samples and found 23 actinomycete isolates effective against Mycobacterium smegmatis through cross-streak screening. Molecular identification confirmed that these isolates belonged to 14 genera of actinomycetes. Out of 23 extracts from these isolates, 15 ethyl acetate organic extracts exhibited strong antimycobacterial activities against M. smegmatis, M. tb H37Ra, and M. tb H37Rv, with MIC values between 125 and 31.25 µg/mL. Importantly, all 15 extracts demonstrated bactericidal activities at their respective MICs against M. tb H37Rv. The other 8 extracts displayed comparatively weaker MIC and MBC ranging 500-250 µg/mL and 1000-500 µg/mL respectively. These extracts were equally effective against drug-resistant and drug-susceptible M. tb clinical isolates. Furthermore, they showed broad antibacterial activity against both gram-positive and gram-negative bacteria, with MICs ranging from 500 to 31.25 µg/mL. The GC-MS analysis of the potent extracts revealed that a wide range of compounds including Phenolics, Peptides, Ergot alkaloids and their derivates may have contributed to anti-mycobacterial activity. The genetic diversity and significant antimicrobial properties of these actinomycetes from extreme environments highlight their potential for developing new antituberculosis and general antibiotic agents, particularly against MDR infections.

Indexed as

ActinobacteriaAnti-Bacterial AgentsAntitubercular AgentsDrug Resistance, Multiple, BacterialLakesMycobacterium tuberculosisAltitudeDrug DiscoveryIndiaMycobacterium smegmatisAnti-Bacterial AgentsAntitubercular AgentsActinomycetesAntibacterialDrug discoveryGC–MSMarine sourcesTuberculosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.